Related Party Transactions (Details Textual) - USD ($) |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Jun. 09, 2015 |
Dec. 21, 2015 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
| Investor [Member] | |||||
| Related Party Transactions (Textual) | |||||
| Number of shares common stock | 1,923,078 | ||||
| Memorial Sloan Kettering Cancer Center [Member] | |||||
| Related Party Transactions (Textual) | |||||
| Royalty description | Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire. | ||||
| Maintenance fees | $ 100,000 | $ 100,000 | $ 200,000 | ||
| Number of shares common stock | 5,700,000 | 1,230.954 | |||
| Sale of stock, Description | MSKCC is permitted to sell its shares subject to a weekly volume limitation of 150,000 shares (which limit may be increased to up to 250,000 shares per week to the extent any prior weekly allotments are not fully used) and applicable law so long as MSKCC maintains at least 25% of its current shareholding in Actinium through December 31, 2016. | ||||